YOUR GO-TO INTELLIGENCE RESOURCE FOR THE SCHOLARLY PUBLISHING INDUSTRY

Wolters Kluwer Health and NEJM Group, the publishers of the New England Journal of Medicine (NEJM), have announced the availability of NEJM AI on Wolters Kluwer's Ovid^® medical research platform.

NEJM AI, a peer-reviewed monthly journal, delves into the responsible integration of artificial intelligence (AI) within clinical medicine. This valuable resource is now accessible to hospitals, government agencies, corporations, health systems, and research institutions worldwide through Ovid's exclusive digital distribution of NEJM Group publications.

The addition of NEJM AI strengthens an existing collaboration between the two entities. Institutions already enjoy online access to NEJM Group journals like NEJM Evidence, NEJM Catalyst, and NEJM Journal Watch through Ovid, enabling users to seamlessly access subscriber content on both NEJM Group sites and the Ovid platform.

NEJM Group launched NEJM AI to foster a deeper understanding and practical use of AI in healthcare. The journal bridges the gap between cutting-edge AI technology and its real-world applications, with the potential to revolutionize patient care and healthcare outcomes. NEJM AI boasts a global editorial team of renowned medical AI experts, uniting the brightest minds in various medical AI disciplines.

Beyond the journal, NEJM Group offers "NEJM AI Grand Rounds," a podcast that tackles critical issues at the intersection of AI, machine learning, and medicine. This podcast will be complemented by initiatives that foster community building, such as events and exclusive subscriber content exploring the frontiers of merging technological advancements with clinical expertise.

Ovid, a comprehensive research platform, offers a wealth of resources within a single, user-friendly interface. Users can access thousands of full-text journal articles, eBooks, databases, and workflow tools, all seamlessly integrated. Wolters Kluwer is committed to trust, transparency, and responsibility – values reflected in both their company ethos and their AI Principles. These principles guide the design, development, and implementation of advanced technologies, ensuring they effectively address the complex challenges faced by their customers.

By providing healthcare institutions with easy access to this NEJM AI, Wolters Kluwer, and NEJM Group are empowering researchers and clinicians to explore the transformative potential of AI in improving patient care and healthcare delivery.